Details of the Drug Formulations

General Information of Drug (ID: DM1SC8M)

• Drug Name: Trimipramine Drug Info
• Synonyms: Sapilent; Stangyl; Surmontil; Surmontyl; Trimeprimina; Trimeprimine; Trimeproprimin; Trimeproprimine; Trimipramina; Trimipraminum; Trimeprimina [Italian]; FI 6120; IL 6001; Beta-Methylimipramine; IL-6001; RP-7162; Rhotrimine (TN); Stangyl (TN); Surmontil (TN); Trimipramina [INN-Spanish]; Trimipraminum [INN-Latin]; Trimipramine (USAN/INN); Trimipramine [USAN:INN:BAN]; Trimipramine, (-)-Isomer; (+)-Trimipramine; (-)-Trimipramine; 1-(3-Dimethylamino-2-methylpropyl)-4,5-dihydro-2,3:6,7-dibenzazepine; 10,11 Dihydro-N,N,beta-trimethyl-5H-dibenz(b,f)azepine-5-propanamine; 10,11-Dihydro-5-(3-dimethylamino-2-methylpropyl)-5H-dibenz(b,f)azepine; 10,11-dihydro-N,N,beta-trimethyl-5H-dibenz[b,f]azepine-5-propanamine; 2'-Metil-3'-dimetilamino-propil-5-iminodibenzile; 2'-Metil-3'-dimetilamino-propil-5-iminodibenzile [Italian]; 3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N,2-trimethylpropan-1-amine; 3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N,2-trimethylpropan-1-amine; 5-(3-(Dimethylamino)-2-methylpropyl)-10,11-dihydro-5H-dibenz(b,f)azepine; 5-(gamma-Dimethylamino-beta-methylpropyl)-10,11-dihydro-5H-dibenzo(b,f)azepine; 5-(gamma-dimethylamino-beta-methylpropyl)-10,11-dihydro-5H-dibenzo[b,f]azepine; 5-[3-(dimethylamino)-2-methylpropyl]-10,11-dihydro-5H-dibenz[b,f]azepine; 5H-Dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-N,N,beta-trimethyl-, (+)-(9CI); 5H-Dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-N,N,beta-trimethyl-, (-)-(9CI); 7162 RP

Indication

Disease Entry	ICD 11	Status	REF
Major depressive disorder	6A70.3	Approved	[1]

• Therapeutic Class: Antidepressants
• Cross-matching ID:
  PubChem CID: 5584
  ChEBI ID: CHEBI:9738
  CAS Number: 3564-75-8
  TTD ID: D00HZV
  VARIDT ID: DR00381
  INTEDE ID: DR1649
  ACDINA ID: D00708

Full List of Drug Formulations Containing This Drug

Trimipramine 50 mg capsule

Company	Formulation ID	FDA Description
Teva Women's Health	F21721	Methylparaben; D&c red no. 28; Lactose monohydrate; Sodium lauryl sulfate; Butylparaben; Fd&c red no. 40; Benzyl alcohol; Fd&c blue no. 1; Fd&c yellow no. 6; Magnesium stearate; Propylparaben; Sodium propionate; Ammonia; Edetate calcium disodium; Ferrosoferric oxide; Potassium hydroxide; Propylene glycol; Titanium dioxide; Gelatin; Shellac
Actavis Pharma; Dr Reddy's Laboratories	F21722	Lactose monohydrate; D&c yellow no. 10; Fd&c red no. 40; Butyl alcohol; Fd&c blue no. 1; Fd&c blue no. 2; Magnesium stearate; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Gelatin; Shellac
Breckenridge Pharmaceutical; CrossMedika S.A.	F21723	D&c red no. 28; Lactose monohydrate; Fd&c red no. 40; Fd&c blue no. 1; Fd&c yellow no. 6; Magnesium stearate; Ammonia; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Gelatin; Shellac

Trimipramine 25 mg capsule

Company	Formulation ID	FDA Description
Teva Women's Health	F21717	Methylparaben; Lactose monohydrate; Sodium lauryl sulfate; Butylparaben; D&c yellow no. 10; Benzyl alcohol; Fd&c blue no. 1; Fd&c yellow no. 6; Magnesium stearate; Propylparaben; Sodium propionate; Ammonia; Edetate calcium disodium; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Gelatin; Shellac
Actavis Pharma; Dr Reddy's Laboratories	F21718	Lactose monohydrate; D&c yellow no. 10; Fd&c red no. 40; Butyl alcohol; Fd&c blue no. 1; Fd&c blue no. 2; Magnesium stearate; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Gelatin; Shellac
CrossMedika S.A.	F21719	Lactose monohydrate; D&c yellow no. 10; Fd&c blue no. 1; Fd&c yellow no. 6; Magnesium stearate; Ammonia; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Gelatin; Shellac
Breckenridge Pharmaceutical	F21720	Lactose monohydrate; D&c yellow no. 10; Fd&c blue no. 1; Fd&c yellow no. 6; Magnesium stearate; Ammonia; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Gelatin; Shellac

Trimipramine 100 mg capsule

Company	Formulation ID	FDA Description
Teva Women's Health	F21713	Lactose monohydrate; D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 1; Fd&c blue no. 2; Indigotindisulfonate sodium; Magnesium stearate; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Aluminum oxide; Gelatin; Shellac
Dr Reddy's Laboratories	F21715	Lactose monohydrate; D&c yellow no. 10; Butyl alcohol; Fd&c blue no. 1; Fd&c blue no. 2; Magnesium stearate; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Gelatin; Shellac
Actavis Pharma	F21716	Lactose monohydrate; Butyl alcohol; Fd&c blue no. 1; Fd&c blue no. 2; Magnesium stearate; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Gelatin; Shellac
Breckenridge Pharmaceutical; CrossMedika S.A.	F21714	Lactose monohydrate; Fd&c blue no. 1; Magnesium stearate; Ammonia; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Gelatin; Shellac

Trimipramine Maleate eq 50mg base capsule

Company	Formulation ID	FDA Description
Odyssey Pharms	F23592	Black Ink; Fd&C Blue 1; Gelatin; Lactose; Magnesium Stearate; Titanium Dioxide; Benzyl Alcohol; D&C Red 28; Edetate Calcium Disodium; Fd&C Red 40; Fd&C Yellow 6; Parabens (Butyl, Propyl, Methyl); Sodium Lauryl Sulfate; Sodium Propionate

Trimipramine Maleate eq 25mg base capsule

Company	Formulation ID	FDA Description
Odyssey Pharms	F23593	Black Ink; Fd&C Blue 1; Gelatin; Lactose; Magnesium Stearate; Titanium Dioxide; Benzyl Alcohol; D&C Yellow 10; Edetate Calcium Disodium; Fd&C Yellow 6; Parabens (Butyl; Propyl; Methyl); Sodium Lauryl Sulfate; Sodium Propionate

References

• [1] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015